Zoetis Inc (ZTS)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $34.06B
Last updated: Nov 17, 2026 at 11:06 AM ET
Zoetis Inc (ZTS) P/E Ratio & Valuation History
Zoetis (ZTS) trades at 12.7x trailing earnings and 3.7x sales. Its P/E of 12.7x is below its 5-year median of 31.4x. Its forward P/E is 12.7x. The median P/E across 10 similar companies is 21.8x.
Current Multiples
Its enterprise value is 11.1x its EBITDA. Its free cash flow yield is 6.6%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 12.7x |
| Forward P/E | 12.7x |
| Price to sales | 3.7x |
| Price to book | 10.5x |
| EV/EBITDA | 11.1x |
| Price to FCF | 15.3x |
| EV/FCF | 18.6x |
| PEG | 4.0 |
| FCF yield | 6.6% |
Historical Medians
Against its 10-year medians, its P/E is 60.2% below 31.9x, its P/S is 58.4% below 8.9x and its P/B is 41.7% below 18.0x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 12.7x | 31.4x | 31.9x |
| P/S | 3.7x | 8.9x | 8.9x |
| P/B | 10.5x | 16.0x | 18.0x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 19.6x in 2025 to 51.9x in 2021. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $125.82 | 19.6x | 5.9x | 16.6x |
| 2024 | $162.93 | 27.5x | 8.0x | 15.4x |
| 2023 | $197.37 | 37.1x | 10.7x | 18.2x |
| 2022 | $146.55 | 30.0x | 8.5x | 15.5x |
| 2021 | $244.03 | 51.9x | 14.9x | 25.5x |
| 2020 | $165.50 | 43.0x | 11.8x | 21.0x |
| 2019 | $132.35 | 36.4x | 10.1x | 23.5x |
| 2018 | $85.54 | 27.2x | 7.1x | 19.0x |
| 2017 | $72.04 | 30.0x | 6.7x | 20.0x |
| 2016 | $53.53 | 27.3x | 5.4x | 17.9x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ZTS
What is ZTS's forward P/E ratio?
Zoetis has a forward P/E ratio of 12.7x.
Is ZTS stock overvalued?
GNG's valuation label for ZTS is Undervalued. Its P/E of 12.7x compares with a median of 21.8x across 10 similar companies.
What is ZTS's price to sales ratio?
Zoetis has a price to sales ratio of 3.7x.
What is Zoetis's average P/E ratio over 5 years?
Zoetis's median P/E over the last 5 years is 31.4x, from 60 month-end values through Oct 2026.
What is ZTS's PEG ratio?
Zoetis has a PEG ratio of 4.0.
ZTS pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts